These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 25089018)
1. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. Song CY; Zeng X; Wang Y; Shi J; Qian H; Zhang Y; Fang JQ; Sheng X; Zheng JM; Chen YX J Gastroenterol Hepatol; 2015 Feb; 30(2):405-12. PubMed ID: 25089018 [TBL] [Abstract][Full Text] [Related]
2. RETRACTED: Sophocarpine displays anti-inflammatory effect via inhibiting TLR4 and TLR4 downstream pathways on LPS-induced mastitis in the mammary gland of mice. Wang D; Xu N; Zhang Z; Yang S; Qiu C; Li C; Deng G; Guo M Int Immunopharmacol; 2016 Jun; 35():111-118. PubMed ID: 27039209 [TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. Wang H; Zhang Q; Chai Y; Liu Y; Li F; Wang B; Zhu C; Cui J; Qu H; Zhu M J Endocrinol Invest; 2015 Oct; 38(10):1083-91. PubMed ID: 25906757 [TBL] [Abstract][Full Text] [Related]
4. Sophocarpine administration preserves myocardial function from ischemia-reperfusion in rats via NF-κB inactivation. Li C; Gao Y; Tian J; Shen J; Xing Y; Liu Z J Ethnopharmacol; 2011 Jun; 135(3):620-5. PubMed ID: 21459139 [TBL] [Abstract][Full Text] [Related]
5. Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. Song CY; Shi J; Zeng X; Zhang Y; Xie WF; Chen YX Toxicol In Vitro; 2013 Apr; 27(3):1065-71. PubMed ID: 23395669 [TBL] [Abstract][Full Text] [Related]
6. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats. Qian H; Shi J; Fan TT; Lv J; Chen SW; Song CY; Zheng ZW; Xie WF; Chen YX World J Gastroenterol; 2014 Feb; 20(7):1822-32. PubMed ID: 24587659 [TBL] [Abstract][Full Text] [Related]
7. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways. Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356 [TBL] [Abstract][Full Text] [Related]
9. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1α-mediated JNK and NF-κB pathways in ApoE-/- mice. Luo Y; Dong X; Yu Y; Sun G; Sun X J Ethnopharmacol; 2015 Apr; 163():241-50. PubMed ID: 25655997 [TBL] [Abstract][Full Text] [Related]
11. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways. Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185 [TBL] [Abstract][Full Text] [Related]
13. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells. Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301 [TBL] [Abstract][Full Text] [Related]
14. [Effects of soothing liver and invigorating spleen recipes on LPS-induced hepatocytes injury of rats and TLR4/p38MAPK signal pathway]. Gong XW; Yang QH; Yan HZ; Zhang YP; Liang YJ; Liu YZ; Zhang Jin-Wen ; Lin CM; Li YY Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):4027-33. PubMed ID: 25751957 [TBL] [Abstract][Full Text] [Related]
15. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955 [No Abstract] [Full Text] [Related]
16. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation. Cui L; Feng L; Zhang ZH; Jia XB Int Immunopharmacol; 2014 Nov; 23(1):294-303. PubMed ID: 25239813 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of sophocarpine on lipopolysaccharide-induced acute lung injury in mice. Lu Y; Xu D; Liu J; Gu L Int Immunopharmacol; 2019 May; 70():180-186. PubMed ID: 30807931 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435 [TBL] [Abstract][Full Text] [Related]
19. Palmitate induces interleukin-8 expression in human aortic vascular smooth muscle cells via Toll-like receptor 4/nuclear factor-κB pathway (TLR4/NF-κB-8). Quan J; Liu J; Gao X; Liu J; Yang H; Chen W; Li W; Li Y; Yang W; Wang B J Diabetes; 2014 Jan; 6(1):33-41. PubMed ID: 23826669 [TBL] [Abstract][Full Text] [Related]
20. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis. Shirai Y; Yoshiji H; Noguchi R; Kaji K; Aihara Y; Douhara A; Moriya K; Namisaki T; Kawaratani H; Fukui H J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]